Allergan Stock Buy Or Sell File

As of April 2026, . The company was acquired by AbbVie (NYSE: ABBV) in a $63 billion deal that officially closed on May 8, 2020.

Because Allergan has been integrated into AbbVie, you can no longer buy or sell "AGN" shares directly. Instead, investors seeking exposure to Allergan's former portfolio—including and Juvederm —must now trade AbbVie stock. Investment Profile for AbbVie (ABBV) allergan stock buy or sell

Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue. As of April 2026,